Yuji Aoki. (2016). Comparison of Diuretic Effects between Empagliflozin, a Sodium-Glucose Co-Transporter 2 Inhibitor With Osmotic Diuresis, and Tolvaptan, a Water Diuretic, in Two Type 2 Diabetic Patients Taking Sodium Diuretics. Diabetes Research, 2(2), 45–49. https://doi.org/10.17140/DROJ-2-128